This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03719/identifier/bindingdb/
n4http://linked.opendata.cz/resource/drugbank/drug/DB03719/identifier/pdb/
n5http://linked.opendata.cz/resource/drugbank/drug/DB03719/identifier/pubchem-compound/
n13http://linked.opendata.cz/resource/drugbank/drug/DB03719/identifier/pubchem-substance/
n12http://linked.opendata.cz/resource/drugbank/drug/DB03719/identifier/drugbank/
n9http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03719
rdf:type
n6:Drug
n6:description
A stable adenosine A1 and A2 receptor agonist. Experimentally, it inhibits cAMP and cGMP phosphodiesterase activity. [PubChem]
n6:group
experimental
owl:sameAs
n9:DB03719 n10:DB03719
dcterms:title
N-Ethyl-5'-Carboxamido Adenosine
adms:identifier
n4:NEC n5:6604901 n11:21220 n12:DB03719 n13:46509074
n6:IUPAC-Name
n7:271B62F7-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B62FD-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B62FC-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B62F9-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B62FA-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B62FB-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B62F5-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B62F3-363D-11E5-9242-09173F13E4C5 n7:271B62F6-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B62F4-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B6303-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B6304-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B62FE-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B62FF-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B6301-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B6300-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B6302-363D-11E5-9242-09173F13E4C5
n6:Bioavailability
n7:271B6309-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B630B-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B630C-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B6308-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B6307-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B630A-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B62F8-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-acidic-
n7:271B6305-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B6306-363D-11E5-9242-09173F13E4C5